AndreaBozzo/ceres-open-data-index huggingface dataset:
Elk Creek Seismic Waveforms 2010 (Part 2 of 7)

Coal bursts (damaging seismic events in underground coal mines) pose a substantial threat to operations and mine workers. The underground coal mines in Colorado’s North Fork Valley (NFV) have experienced many coal bursts, often with distinct characteristics from those of other US coal mining regions. To better understand these events and manage their associated risks, the National Institute for Occupational Safety and Health undertook a long-term monitoring campaign at the Elk Creek Mine in the NFV. The monitoring efforts included a seismic network composed of both surface and underground sensors, borehole pressure cells (BPCs), instrumented support Cans, convergence monitors, ground condition surveys, and several other data sources. This dataset consists of the event waveform files from the seismic network for the 983,379 events that were detected during the monitoring campaign. The waveforms are stored in HDF5 files that are broken up by week. Within the HDF5 files, the data are organized by station id, event time, and channel. The amplitudes are velocity in meters/second.
 
This is download 3 of 49 and corresponds to the time range between March 15, 2010, and September 26, 2010.
Compound 525167: Hexaethylene glycol, monoallyl ether, acetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-[2-[2-(2-prop-2-enoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethyl acetate. Molecular Formula: C17H32O8. Molecular Weight: 364.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529005: Benzene, 1,2,3-trimethyl-5-(2-propenyl)

Chemical compound data from PubChem database. IUPAC Name: 1,2,3-trimethyl-5-prop-2-enylbenzene. Molecular Formula: C12H16. Molecular Weight: 160.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527625: 2-Chloro-1-(chloromethyl)-4-methylbenzene

Chemical compound data from PubChem database. IUPAC Name: 2-chloro-1-(chloromethyl)-4-methylbenzene. Molecular Formula: C8H8Cl2. Molecular Weight: 175.05. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529479: 2,2,8,8-Tetramethyl-5,5-bis(((trimethylsilyl)oxy)methyl)-3,7-dioxa-2,8-disilanonane

Chemical compound data from PubChem database. IUPAC Name: trimethyl-[3-trimethylsilyloxy-2,2-bis(trimethylsilyloxymethyl)propoxy]silane. Molecular Formula: C17H44O4Si4. Molecular Weight: 424.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Kentucky (KY)

This report uses 2008 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past year alcohol use disorder and illicit drug use disorder among persons aged 12 or older for Kentucky overall and for substate regions within Kentucky. Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE).
Publications Using SAMHSA DataIncidence Tables (Standard Errors and P Values) - 4.1 to 4.16

These detailed tables present standard errors for totals and prevalence estimates of substance use initiation from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens (including LSD, PCP, Ecstasy), inhalants, and the nonmedical use of prescription-type pain relievers (including OxyContin), tranquilizers, stimulants, sedatives, alcohol, and tobacco products (including cigarettes, smokeless tobacco, and cigars).  Standard errors are provided by age group and gender. Standard errors are provided for both 2012 and 2011
National Study of the Incidence of Child Abuse and Neglect 1987 (NIS-2)

The purpose of the second national incidence study was to assess the current national incidence of child abuse and neglect, and to determine how the severity, frequency, and character of child maltreatment changed since the first national incidence study.  As a follow-up to the first national incidence study, the second study followed essentially the same design.  However, this study included an updated set of definitions based on the “harm standard.”  Original definitions (from 1980) were also used so that comparisons could be made to the first study.

Investigators: National Center on Child Abuse and Neglect
Surfactant alteration and replacement in acute respiratory distress syndrome

The acute respiratory distress syndrome (ARDS) is a frequent, life-threatening disease in which a marked increase in alveolar surface tension has been repeatedly observed. It is caused by factors including a lack of surface-active compounds, changes in the phospholipid, fatty acid, neutral lipid, and surfactant apoprotein composition, imbalance of the extracellular surfactant subtype distribution, inhibition of surfactant function by plasma protein leakage, incorporation of surfactant phospholipids and apoproteins into polymerizing fibrin, and damage/inhibition of surfactant compounds by inflammatory mediators. There is now good evidence that these surfactant abnormalities promote alveolar instability and collapse and, consequently, loss of compliance and the profound gas exchange abnormalities seen in ARDS. An acute improvement of gas exchange properties together with a far-reaching restoration of surfactant properties was encountered in recently performed pilot studies. Here we summarize what is known about the kind and severity of surfactant changes occuring in ARDS, the contribution of these changes to lung failure, and the role of surfactant administration for therapy of ARDS.
Parallel evolution of histophagy in ciliates of the genus

Background
          Species of Tetrahymena were grouped into three complexes based on morphological and life history traits: the pyriformis complex of microstomatous forms; the patula complex of microstome-macrostome transformers; and the rostrata complex of facultative and obligate histophages. We tested whether these three complexes are paraphyletic using the complete sequence of the small subunit rDNA (SSrDNA).
        
        
          Results
          In addition to the 16 species of Tetrahymena whose SSrDNA sequences are known, we sequenced the complete SSrDNA from the following histophagous Tetrahymena species; Tetrahymena bergeri, Tetrahymena mobilis, Tetrahymena rostrata, and Tetrahymena setosa as well as the macrostome species Tetrahymena vorax. We also included a ciliate tentatively identified as Lambornella sp., a parasite of the mosquito Aedes sp. We confirmed earlier results using SSrDNA, which showed two distinct clusters of Tetrahymena species: the australis group and borealis group. The genetic distances among Tetrahymena are in general very small. However, all nodes were supported by high bootstrap values. With the exception of T. bergeri and T. corlissi, which are both histophagous and group as sister species, all other histophagous Tetrahymena species are most closely related to a bacterivorous species. Furthermore, Lambornella sp. and T. empidokyrea, both mosquito parasites, are sister species, although there is a considerable genetic distance between them.
        
        
          Conclusions
          There has been parallel evolution of histophagy in the genus Tetrahymena and the three classical species complexes are paraphyletic. As the genus Lambornella arises within the Tetrahymena clade, it is not likely a defensible one.
Patent AT-E401776-T1: [Translated] ELEVATOR CONVEYOR ELEMENTS FOR AGRICULTURAL HARVESTERS

An agricultural harvesting machine (10) comprises crop processing means (16) and an elevator assembly (23) for conveying harvested crop material to said crop processing means (16). The elevator assembly comprises an elevator housing (50) and endless elevator means mounted for rotation in said housing (50), said elevator means having lower and upper lower runs (66a, 66b). Shielding means, such as an intermediate plate (70, 71), shield said the lower elevator run (66a) from the upper run (66b). Access to the interior of the elevator assembly (23) can be gained through hatch means (82) that comprise a split door (85, 86), which can be opened without requiring a large space between the elevator assembly and the operator's platform (14).
Influenza, COVID-19, and RSV Intensive Care Unit Admissions

Since 2010, influenza cases with intensive care unit (ICU) hospitalization have been reportable in Illinois. As of May 2024, ICU hospitalizations associated with RSV and COVID-19 have also become reportable conditions. All hospitals in Illinois are required to report demographic, clinical, laboratory, and epidemiological information for patients admitted to the ICU were test positive for influenza, RSV, or SARS-CoV-2.

This dataset includes aggregated weekly ICU admissions for Chicago residents who meet the established reporting criteria. Influenza data begins with the 2015-2016 season (starting in October 2015), while data for RSV and COVID-19 begin in May 2024, aligning with the start of mandatory reporting for those diseases. All data are summarized weekly and categorized by disease, age group, and race/ethnicity. Reported metrics include the weekly count and percentage of cases by demographic groups, as well as cumulative totals, cumulative percentages and cumulative incidence rates per 100,000 for the season to date. Cumulative rates are calculated using the U.S. Census Bureau American Community Survey 1-year population estimates. Because reporting requirements for RSV and COVID-19 began in May 2024, data for 2023-2024 season are incomplete, and cumulative rates for that season were not calculated. Most seasons span 52 weeks and do not include an epidemiologic week 53; however, seasons with 53 weeks occasionally occur. A week 53 value for rate_cumulative is provided for all seasons to allow for comparisons of incidence rates by season without breaks in visualization charts. For seasons without a week 53, the rate_cumulative value is calculated as the average of the values from week 52 and week 1. 

All data are provisional and subject to change. Information is updated as additional details are received. At any given time, this dataset reflects data currently known to CDPH. Numbers in this dataset may differ from other public sources.
Compound 529882: 2-(2-Furyl)-5(6)-acetylpyrazine

Chemical compound data from PubChem database. IUPAC Name: 1-[5-(furan-2-yl)pyrazin-2-yl]ethanone. Molecular Formula: C10H8N2O2. Molecular Weight: 188.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528913: Thiophene, 2-(1-methylpropyl)thio

Chemical compound data from PubChem database. IUPAC Name: 2-butan-2-ylsulfanylthiophene. Molecular Formula: C8H12S2. Molecular Weight: 172.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Emergency Department Visits for Drug-Related Suicide Attempts among Middle-Aged Adults Aged 45 to 64

This short report uses data on drug-related emergency department (ED) visits from the Drug Abuse Warning Network (DAWN) to examine the trends and characteristics of ED visits involving drug-related suicide attempts among ED patients aged 45-64 in 2011. The report discusses the patterns for male and female patients, the drugs most frequently involved in the suicide attempt-related ED visits, and the outcome of the visits. Findings from 2011 are compared with 2005 data. The report notes that current suicide prevention public health efforts are directed at primarily young people and the elderly, but that the findings of this analysis--the increase in drug-related suicide attempts among adults ages 45-64--underscore the importance of understanding risk factors and developing appropriate prevention strategies for this age group.
Compound 529204: Butanoic acid, 2-amino, O,N-bis-DMTBS

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] 2-[[tert-butyl(dimethyl)silyl]amino]butanoate. Molecular Formula: C16H37NO2Si2. Molecular Weight: 331.64. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525884: N,N-Dimethyl-N'-(4-chlorophenyl)-isobutyramidine

Chemical compound data from PubChem database. IUPAC Name: N'-(4-chlorophenyl)-N,N,2-trimethylpropanimidamide. Molecular Formula: C12H17ClN2. Molecular Weight: 224.73. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526926: Isopropyladamantyl ketone

Chemical compound data from PubChem database. IUPAC Name: 1-(1-adamantyl)-2-methylpropan-1-one. Molecular Formula: C14H22O. Molecular Weight: 206.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Publications Using SAMHSA Data2012 Uniform Reporting System (URS) Tables for Mississippi

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2012. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 528816: Flavanone, 5,7-dihydroxy, mono-TMS

Chemical compound data from PubChem database. IUPAC Name: 5-hydroxy-2-phenyl-7-trimethylsilyloxy-2,3-dihydrochromen-4-one. Molecular Formula: C18H20O4Si. Molecular Weight: 328.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Enhancing CCWIS Acceptance and Utilization for Frontline Users: Findings from an Empirical Study

Presented July 26, 2023, this webinar provides review of an empirical study on the factors that predict technology acceptance in social work, as well as an overview of the relationship between social workers and technology, and tips for leading large-scale organizational change.

Audio Description Version

Metadata-only record linking to the original dataset. Open original dataset below.
AFCARS Report #14

This report provides preliminary estimaes of AFCARS data for FY 2006. Preliminary reports of AFCARS data include data received by September 30 for the report period ending March 31 and by March 31 for the report period ending September 30. This generally encompasses the required data submissions and submission of corrected data by States to avoid possible financial penalties.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E399747-T1: [Translated] METHOD FOR PRODUCING ALKYLAROMATIC COMPOUNDS

Production of alkylaromatic compounds (I), by reacting 3-30C olefins (II) (or alcohols forming (II) under the reaction conditions) with aromatic hydrocarbons (III) in presence of an alkylation catalyst (IV), is carried out in a cascade of at least two reactors each containing (IV), where at least 80 % of (III) is supplied to the first reactor of the cascade and at least 40 % of (II) is supplied after the first reactor. An independent claim is included for the preparation of alkylarylsulfonates (A), by: (1) converting a 4C olefin mixture over a metathesis catalyst to give an olefin mixture containing 2-pentene and/or 2-hexene; (2) catalytically dimerizing the 2-pentene and/or 2-hexene (optionally after isolation) to give a mixture containing 10-12C olefins, optionally separating the 10-12C olefins and separating 5-30 wt. % (based on the 10-12C olefins) of low-boiling components of the 10-12C olefins; (3) reacting the obtained 10-12C olefin mixture with (III) in presence of (IV) to give alkylaromatic compounds (I'), optionally with addition of 0-60 wt. % (based on the 10-12C olefin mixture) of linear olefins before the reaction; (4) sulfonating (I') and neutralizing to give (A), optionally with addition of 0-60 wt. % (based on (I')) of linear alkylbenzenes (provided that no mixing has been carried out in the previous step); and (5) optionally mixing the obtained (A) with optionally with addition of 0-60 wt. % (based on (A)) of linear aralkylsulfonates (provided that no mixing has been carried out either of the previous two steps); The novel feature being that the reaction in the alkylation stage (3) is carried out as for the present procedure for preparing (I).
National Survey of Substance Abuse Treatment Services (N-SSATS): 2002 Data on Substance Abuse Treatment Facilities

This report presents results from the 2002 National Survey of Substance Abuse Treatment Services (N-SSATS), an annual survey of facilities providing substance abuse treatment. Conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), the NSSATS is designed to collect data on the location, characteristics, and use of alcoholism and drug abuse treatment facilities and services throughout the 50 states, the District of Columbia, and other U.S. jurisdictions.
The CRASH trial protocol (Corticosteroid randomisation after significant head injury) [ISRCTN74459797]

Background
          Worldwide, millions of people are treated each year for significant head injury. A substantial proportion die, and many more are disabled. If short term corticosteroid infusion could be reliably shown to reduce these risks by just a few percent then this might affect the treatment of a few hundred thousand patients a year, protecting thousands from death or long term disability.
        
        
          Study design
          CRASH is a large simple, placebo-controlled trial of the effects of a 48-hour infusion of corticosteroids on death and on neurological disability, among adults with head injury and some impairment of consciousness. Head injured patients with impaired consciousness who are judged to be 16 years or older are eligible if the responsible doctor is, for any reason, substantially uncertain whether or not to use corticosteroids.
        
        
          Organisation
          The CRASH trial will determine reliably the effects on death and disability of a short corticosteroid infusion following significant head injury. To detect or refute improvements of only a few percent in outcome, many thousands of acute head injury patients must be randomised between control and steroid infusions. Such large numbers will be possible only if hundreds of doctors and nurses can collaborate in the participating emergency departments. Since they are busy, and working in emergency situations, the trial involves them in almost no extra work: no special investigations or changes to usual management are required, and data collection is absolutely minimal. The trial is on-going and new collaborators are welcome. Further information about the trial is available at
Compound 525544: 2-(tert-Butyl-dimethyl-silanyloxy)-3-propyl-quinoxaline

Chemical compound data from PubChem database. IUPAC Name: tert-butyl-dimethyl-(3-propylquinoxalin-2-yl)oxysilane. Molecular Formula: C17H26N2OSi. Molecular Weight: 302.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic

NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic - 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
  * Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Compound 528924: Benzaldehyde, 2-hydroxy, 3-chloro-5-tert.-octyl, oxime, TMS

Chemical compound data from PubChem database. IUPAC Name: 1-[3-chloro-5-(2,4,4-trimethylpentan-2-yl)-2-trimethylsilyloxyphenyl]-N-trimethylsilyloxymethanimine. Molecular Formula: C21H38ClNO2Si2. Molecular Weight: 428.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
SHIP Adolescents Who Use Tobacco Products 2010, 2013-2014, 2016, 2018, 2021

Adolescents Who Use Tobacco Products  - This indicator shows the percentage of adolescents (public high school students) who used any tobacco product in the last 30 days. Preventing youth from using tobacco products is critical to improving the health of Marylanders. This highly addictive behavior can lead to costly illnesses and death to users and those exposed to secondhand smoke. <a href ="https://health.maryland.gov/pophealth/Documents/SHIP/SHIP%20Lite%20Data%20Details/Adolescents%20Who%20Use%20Tobacco%20Products.pdf" > Link to Data Details </a>